Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Two different teams from the Medical Sciences Division have received a share of $14 million in funding from the Chan Zuckerberg Initiative as one of 29 projects that will explore emerging ideas regarding the role of inflammation in disease.

None

 

Two different teams from across Medical Sciences have been awarded a grant from the Chan Zuckerberg Initiative.

Associate Professor Mathilda Mommersteeg, Professor Paul Riley,and Professor Robin Choudhury will use their award to perform single cell analysis of inflammation during heart regeneration. Professor Mark Coles, Dr Calliope Dendrou, and Dr Anita Milicic will combine their expertise to create the first map of adjuvant-induced inflammation on tissues from diverse ethnic groups and build a unique resource that will inform more inclusive global vaccine design and development.

While inflammation is a natural defense that helps our bodies maintain a healthy state, chronic inflammation results in harmful diseases such as asthma, arthritis, and heart disease, and can also play a role in organ failure, neurodegenerative diseases like Alzheimer's, and many other conditions such as COVID-19.

The CZI welcomed 80 researchers to work on the two-year pilot projects, 75 percent of which are led by early-career scientists within six years of starting their independent position. Grantee teams are made up of two to three investigators with distinct areas of expertise and they represent 11 countries. 

Read full stories

Professor Mark Coles, Dr Calliope Dendrou, and Dr Anita Milicic research is explained in full on their departmental websites:

- The Jenner Institute

- The Wellcome Centre for Human Genetics

- Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences

Associate Professor Mathilda Mommersteeg, Professor Paul Riley,and Professor Robin Choudhury research is explained more fully here:

- Department of Physiology, Anatomy and Genetics

Similar stories

Regular meat consumption linked with a wide range of common diseases

Research

Regular meat consumption is associated with a range of diseases that researchers had not previously considered, according to a large, population-level study conducted by a team at the University of Oxford.

New data show vaccines reduce severe COVID-19 in older adults

Coronavirus COVID-19 Research

New data show both Oxford / AstraZeneca vaccine and the Pfizer-BioNTech vaccines significantly reduce severe COVID-19 in older adults.

Singula Bio, a new Oxford spin-out company - Cancer need not be fatal

General Innovation Research

Singula Bio, a bold new seed-stage biotechnology company spun out of Oxford University, has been launched with the intention of helping show that cancer need not be fatal. Led by three Oxford cancer specialists, the firm is aims to become a world leader in therapies to use against difficult-to-treat solid malignancies such as ovarian cancer - using the body’s own immune system to fight previously fatal cancers.

Major rise in public support for COVID vaccine – Oxford study

Coronavirus COVID-19 General Research

More than three quarters of people in the UK now say they are ’very likely’ to have the vaccine – up from 50% among the same group of survey respondents five months ago –according to a two-wave Oxford University survey published today.

Coronavirus vaccination linked to substantial reduction in hospitalisation, real-world data suggests

Coronavirus COVID-19 General Research

The first study to describe the effects in real-world communities of the Oxford coronavirus vaccine has been reported in a pre-print publication today, showing a clear reduction in the risk of hospitalisation from COVID-19 amongst those who have received the vaccine.